{
    "organizations": [],
    "uuid": "d21a9db13f46017f8222801d345e52cd04ccedec",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/health-asacol/allergan-wins-last-minute-halt-of-asacol-antitrust-trial-idUSL2N1PK27Q",
    "ord_in_thread": 0,
    "title": "Allergan wins last-minute halt of Asacol antitrust trial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Allergan PLC on Thursday won its last-minute bid at a federal appeals court to delay a trial set for next week in a class action lawsuit claiming it suppressed generic competition for its ulcerative colitis drug Asacol.\nThe 1st U.S. Circuit Court of Appeals in Boston ordered lower-court proceedings in the case be put on hold while it reviews a judgeâ€™s decision to certify a class of health plans and other indirect drug purchasers.\nTo read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2GhrXxv\n ",
    "published": "2018-01-26T06:17:00.000+02:00",
    "crawled": "2018-01-26T12:05:27.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "allergan",
        "plc",
        "thursday",
        "bid",
        "federal",
        "appeal",
        "court",
        "delay",
        "trial",
        "set",
        "next",
        "week",
        "class",
        "action",
        "lawsuit",
        "claiming",
        "suppressed",
        "generic",
        "competition",
        "ulcerative",
        "colitis",
        "drug",
        "asacol",
        "1st",
        "circuit",
        "court",
        "appeal",
        "boston",
        "ordered",
        "proceeding",
        "case",
        "put",
        "hold",
        "review",
        "judge",
        "decision",
        "certify",
        "class",
        "health",
        "plan",
        "indirect",
        "drug",
        "purchaser",
        "read",
        "full",
        "story",
        "westlawnext",
        "practitioner",
        "insight",
        "click"
    ]
}